SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART)
Preprint
Maitland K. et al, (2024)
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial
Journal article
Hamaluba M. et al, (2023), Wellcome Open Research, 8, 182 - 182
Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial.
Journal article
Kimathi D. et al, (2023), Lancet Infect Dis
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Journal article
Odera DO. et al, (2023), Sci Transl Med, 15
A global core outcome measurement set for snakebite clinical trials.
Journal article
Abouyannis M. et al, (2023), Lancet Glob Health, 11, e296 - e300
Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.
Journal article
Hamaluba M. et al, (2023), Wellcome Open Res, 8
Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial
Journal article
Wamae K. et al, (2022), Wellcome Open Research, 7, 95 - 95
A pragmatic randomized controlled trial of standard care versus steroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA)
Journal article
Lucinde R. et al, (2022), Wellcome Open Research, 7, 269 - 269
Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
Journal article
van der Pluijm RW. et al, (2022), Lancet Infect Dis, 22, 765 - 766
Targeted amplicon deep sequencing of ama1 and mdr1 to track within-host P. falciparum diversity throughout treatment in a clinical drug trial.
Journal article
Wamae K. et al, (2022), Wellcome Open Res, 7
Undertaking Community Engagement for a Controlled Human Malaria Infection Study in Kenya: Approaches and Lessons Learnt.
Journal article
Mumba N. et al, (2022), Front Public Health, 10
Incidence of chikungunya virus infections among Kenyan children with neurological disease: a prospective cohort study
Journal article
Nyamwaya D. et al, (2021)
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomized, double-blind, non-inferiority trial
Preprint
Juan-Giner A. et al, (2020)
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Journal article
Voysey M. et al, (2020), Lancet
Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity
Journal article
Kapulu MC. et al, (2018), Wellcome Open Research, 3, 155 - 155